Clinical Positron Imaging

Journal

Publication Venue For

  • The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides 2019
  • Fluorescence Imaging for Cancer Screening and Surveillance.  19:645-655. 2017
  • Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.  19:610-616. 2017
  • Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.  19:512-521. 2017
  • [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.  18:952-959. 2016
  • A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.  18:325-333. 2016
  • Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques.  18:232-242. 2016
  • Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.  18:90-98. 2016
  • Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury.  17:786-792. 2015
  • Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.  16:85-94. 2014
  • IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques.  17:49-57. 2014
  • Effects of Chelator Modifications on 68Ga-Labeled [Tyr 3]Octreotide Conjugates.  15:606-613. 2013
  • 18F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts.  14:237-244. 2012
  • A genetic strategy for combined screening and localized imaging of breast cancer.  13:452-461. 2011
  • DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 Therapy.  13:94-103. 2011
  • International Standard Serial Number (issn)

  • 1536-1632
  • Electronic International Standard Serial Number (eissn)

  • 1860-2002